(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -768.57%-12.05M | 2,499.26%13.03M | -303.70%-3.63M | -286.94%-1.57M | -109.08%-140K | -154.07%-1.39M | 82.84%-543K | 113.79%1.78M | 136.82%842K | 154.39%1.54M |
Net income from continuing operations | -26.17%8.83M | -156.03%-4.76M | -36.08%26.09M | -120.20%-5.76M | 789.77%11.39M | -4.81%11.96M | 652.57%8.49M | 159.24%40.81M | 131.31%28.5M | -68.92%1.28M |
Operating gains losses | 60.04%-4.4M | 104.72%439K | 31.93%-31.66M | 96.38%-1.69M | -5,462.78%-9.65M | -137,850.00%-11.02M | -44,371.43%-9.3M | -190.27%-46.52M | -163.08%-46.73M | 105.24%180K |
Depreciation and amortization | 12,988.89%4.71M | 8,277.78%3.02M | -2.05%143K | 0.00%36K | -2.78%35K | -2.70%36K | -2.70%36K | -1.35%146K | -2.70%36K | -2.70%36K |
Asset impairment expenditure | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -178.67%-6M | ---- | ---- |
Unrealized gains and losses of investment securities | --0 | 29.41%-1.65M | ---3.36M | -76.34%3.92M | 25.39%-2.51M | 81.65%-2.43M | ---2.34M | --0 | --16.58M | -54.95%-3.36M |
Remuneration paid in stock | 235.50%3M | 221.10%5.13M | 274.48%6.16M | 309.05%3.07M | -52.41%602K | 575.00%893K | 977.47%1.6M | -48.16%1.65M | -29.75%751K | 631.21%1.27M |
Other non cashItems | 1,720.31%11.41M | 537.87%2.93M | -162.57%-2.88M | -114.83%-755K | -127.41%-755K | -501.71%-704K | -1,755.56%-668K | 609.71%4.61M | 508.24%5.09M | -709.76%-332K |
Change In working capital | -16,068.64%-19.08M | 384.01%7.93M | -73.58%1.88M | -115.21%-398K | -69.64%752K | -103.40%-118K | 211.65%1.64M | 198.79%7.1M | 273.59%2.62M | 263.28%2.48M |
-Change in receivables | ---5.47M | -600.24%-6.22M | -87.99%678K | ---- | ---- | --0 | 188.41%1.24M | 221.93%5.64M | ---- | ---- |
-Change in inventory | ---5.89M | --14.08M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
-Change in prepaid assets | 131.63%725K | -2,933.33%-340K | -190.00%-9K | ---- | ---- | 17.67%313K | -95.20%12K | 104.26%10K | ---- | ---- |
-Change in payables and accrued expense | -1,858.00%-8.44M | 5.99%407K | -16.54%1.21M | ---- | ---- | -10.51%-431K | 223.08%384K | 162.23%1.45M | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 424.11%4.46M | 2,499.26%13.03M | -303.70%-3.63M | -286.94%-1.57M | -109.08%-140K | -153.68%-1.38M | 82.84%-543K | 113.79%1.78M | 136.82%842K | 154.39%1.54M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -1,657.18%-10.95M | 9,798.76%63.75M | 177.52%2.86M | 41.60%759K | 129.00%758K | 471.54%703K | 1,433.33%644K | -73.58%1.03M | 1,575.00%536K | 635.56%331K |
Capital expenditure reported | ---- | -25,082.76%-7.3M | -775.00%-35K | --0 | 66.67%-1K | ---- | -2,800.00%-29K | 87.10%-4K | --0 | 25.00%-3K |
Net PPE purchase and sale | -245,460.00%-12.28M | ---- | ---- | ---- | ---- | ---5K | ---- | ---- | ---- | ---- |
Net business purchase and sale | ---102K | --70.2M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Interest received (cash flow from investment activities) | 102.40%1.43M | 26.00%848K | 179.83%2.9M | 41.60%759K | 127.25%759K | 475.61%708K | 1,465.12%673K | 154.55%1.04M | 1,118.18%536K | 581.63%334K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -1,657.18%-10.95M | 9,798.76%63.75M | 177.52%2.86M | 41.60%759K | 129.00%758K | 471.54%703K | 1,433.33%644K | -73.58%1.03M | 1,575.00%536K | 635.56%331K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -2,641.94%-850K | -2,922.58%-937K | 16.92%-108K | 54.84%-14K | 0.00%-32K | 6.06%-31K | 8.82%-31K | -129.48%-130K | 6.06%-31K | -130.19%-32K |
Net issuance payments of debt | -10,380.65%-3.25M | -3,377.42%-1.08M | 2.31%-127K | -6.45%-33K | 0.00%-32K | 6.06%-31K | 8.82%-31K | -1.56%-130K | 6.06%-31K | 0.00%-32K |
Proceeds from stock option exercised by employees | --2.4M | --181K | --19K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net other financing activities | ---- | ---40K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -2,641.94%-850K | -2,922.58%-937K | 16.92%-108K | 54.84%-14K | 0.00%-32K | 6.06%-31K | 8.82%-31K | -129.48%-130K | 6.06%-31K | -130.19%-32K |
Net cash flow | ||||||||||
Beginning cash position | 132.86%130.8M | -1.50%55.27M | 4.84%56.11M | 2.49%56.08M | 4.71%55.5M | 11.49%56.17M | 4.84%56.11M | -13.89%53.52M | -2.02%54.72M | -9.47%53.01M |
Current changes in cash | -940.28%-7.33M | 108,241.43%75.84M | -132.69%-878K | -161.54%-829K | -68.17%586K | -126.55%-705K | 102.22%70K | 131.28%2.69M | 158.87%1.35M | 168.59%1.84M |
Effect of exchange rate changes | -1,331.43%-431K | -3,712.50%-305K | 138.54%37K | -58.33%20K | 92.31%-10K | 202.94%35K | -140.00%-8K | -128.57%-96K | 245.45%48K | -490.91%-130K |
End cash Position | 121.68%123.04M | 132.86%130.8M | -1.50%55.27M | -1.50%55.27M | 2.49%56.08M | 4.71%55.5M | 11.49%56.17M | 4.84%56.11M | 4.84%56.11M | -2.02%54.72M |
Free cash from | -465.48%-7.82M | 1,100.87%5.73M | -306.12%-3.67M | -286.94%-1.57M | -109.16%-141K | -153.88%-1.38M | 81.93%-572K | 112.33%1.78M | 136.62%842K | 154.21%1.54M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data